Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125789181 | 12578918 | 1 | I | 20151223 | 20160721 | 20160721 | PER | US-TEVA-621817USA | TEVA | 0.00 | F | Y | 81.72000 | KG | 20160721 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125789181 | 12578918 | 1 | PS | LISINOPRIL AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELISINOPRIL | 1 | Unknown | Y | 75776 | ||||||||||
| 125789181 | 12578918 | 2 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | 25 MILLIGRAM DAILY; | U | 83177 | 25 | MG | TABLET | QD | |||||
| 125789181 | 12578918 | 3 | SS | LOSARTAN POTASSIUM W/HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | 1 DOSAGE FORMS DAILY; 50MG/12.5 MG | U | 0 | 1 | DF | TABLET | QD | |||||
| 125789181 | 12578918 | 4 | SS | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | 10 MILLIGRAM DAILY; | U | 0 | 5 | MG | BID | ||||||
| 125789181 | 12578918 | 5 | SS | NIFEDICAL XL | NIFEDIPINE | 1 | Oral | 30 MILLIGRAM DAILY; | 0 | 30 | MG | TABLET | QD | ||||||
| 125789181 | 12578918 | 6 | SS | LISINOPRIL. | LISINOPRIL | 1 | Oral | 25 MILLIGRAM DAILY; | Y | 0 | 25 | MG | TABLET | QD | |||||
| 125789181 | 12578918 | 7 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | Y | 0 | ||||||||||
| 125789181 | 12578918 | 8 | SS | LOSARTAN. | LOSARTAN | 1 | Oral | Y | 0 | 50 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125789181 | 12578918 | 1 | Hypertension |
| 125789181 | 12578918 | 2 | Hypertension |
| 125789181 | 12578918 | 3 | Hypertension |
| 125789181 | 12578918 | 4 | Hypertension |
| 125789181 | 12578918 | 5 | Hypertension |
| 125789181 | 12578918 | 6 | Hypertension |
| 125789181 | 12578918 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125789181 | 12578918 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125789181 | 12578918 | Bladder disorder | |
| 125789181 | 12578918 | Blood pressure systolic increased | |
| 125789181 | 12578918 | Bradyphrenia | |
| 125789181 | 12578918 | Cough | |
| 125789181 | 12578918 | Decreased appetite | |
| 125789181 | 12578918 | Drug ineffective | |
| 125789181 | 12578918 | Emotional disorder | |
| 125789181 | 12578918 | Headache | |
| 125789181 | 12578918 | Incontinence | |
| 125789181 | 12578918 | Malaise | |
| 125789181 | 12578918 | Pain | |
| 125789181 | 12578918 | Personality change | |
| 125789181 | 12578918 | Rash | |
| 125789181 | 12578918 | Thinking abnormal | |
| 125789181 | 12578918 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125789181 | 12578918 | 1 | 2012 | 0 | ||
| 125789181 | 12578918 | 4 | 2002 | 0 | ||
| 125789181 | 12578918 | 5 | 20150724 | 0 | ||
| 125789181 | 12578918 | 7 | 2000 | 0 |